A phase I study of daily afatinib, an irreversible ErbB...

  • Main
  • 2015 / 8
  • A phase I study of daily afatinib, an irreversible ErbB...
European Journal of Cancer 2015 / 8

A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours

Suder, A., Ang, J.E., Kyle, F., Harris, D., Rudman, S., Kristeleit, R., Solca, F., Uttenreuther-Fischer, M., Pemberton, K., Pelling, K., Schnell, D., de Bono, J., Spicer, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2015.07.041
Date:
August, 2015
File:
PDF, 763 KB
english, 2015
Conversion to is in progress
Conversion to is failed